Francesca D’Avanzo

879 total citations
8 papers, 255 citations indexed

About

Francesca D’Avanzo is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Francesca D’Avanzo has authored 8 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Francesca D’Avanzo's work include Advanced Breast Cancer Therapies (2 papers), Estrogen and related hormone effects (2 papers) and Cancer Risks and Factors (2 papers). Francesca D’Avanzo is often cited by papers focused on Advanced Breast Cancer Therapies (2 papers), Estrogen and related hormone effects (2 papers) and Cancer Risks and Factors (2 papers). Francesca D’Avanzo collaborates with scholars based in Italy, United Kingdom and Spain. Francesca D’Avanzo's co-authors include Alessandra Gennari, Simone Nardin, Chiara Saggia, Valentina Rossi, Sara Rubinelli, Veronica Martini, Antonio Sica, Paola Maggiora, Gianluca Aimaretti and Paolo Marzullo and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Cancers.

In The Last Decade

Francesca D’Avanzo

5 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca D’Avanzo Italy 3 133 61 58 52 26 8 255
Chiara Saggia Italy 6 177 1.3× 42 0.7× 65 1.1× 71 1.4× 26 1.0× 15 309
Simone Nardin Italy 6 144 1.1× 43 0.7× 50 0.9× 61 1.2× 32 1.2× 21 278
Bożena Kukiełka-Budny Poland 5 117 0.9× 68 1.1× 66 1.1× 43 0.8× 22 0.8× 8 266
Nadeem Bilani United States 10 161 1.2× 82 1.3× 105 1.8× 74 1.4× 32 1.2× 38 364
Jinnan Gao China 10 124 0.9× 41 0.7× 30 0.5× 71 1.4× 13 0.5× 37 287
Sarah M. Lima United States 5 131 1.0× 36 0.6× 55 0.9× 20 0.4× 13 0.5× 14 238
Valentina Rossi Italy 5 197 1.5× 54 0.9× 50 0.9× 68 1.3× 33 1.3× 8 371
Maria do Socorro Maciel Brazil 7 117 0.9× 57 0.9× 77 1.3× 25 0.5× 17 0.7× 11 265
Charmaine Martin United States 4 185 1.4× 125 2.0× 106 1.8× 47 0.9× 26 1.0× 6 412

Countries citing papers authored by Francesca D’Avanzo

Since Specialization
Citations

This map shows the geographic impact of Francesca D’Avanzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca D’Avanzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca D’Avanzo more than expected).

Fields of papers citing papers by Francesca D’Avanzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca D’Avanzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca D’Avanzo. The network helps show where Francesca D’Avanzo may publish in the future.

Co-authorship network of co-authors of Francesca D’Avanzo

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca D’Avanzo. A scholar is included among the top collaborators of Francesca D’Avanzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca D’Avanzo. Francesca D’Avanzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Nardin, Simone, Andrea Delbarba, Francesca D’Avanzo, et al.. (2025). Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer: Insights into Toxicities and Their Management. Cancers. 17(17). 2726–2726.
2.
Cattrini, Carlo, Marcello Manfredi, Paola Barboro, et al.. (2022). Lipidomic profiling in patients with heavily pretreated castration-resistant prostate cancer.. Journal of Clinical Oncology. 40(6_suppl). 174–174.
3.
Biello, Federica, Francesca Platini, Francesca D’Avanzo, et al.. (2021). Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights. Biomolecules. 11(1). 125–125. 34 indexed citations
4.
Martini, Veronica, et al.. (2020). Oncolytic virotherapy: new weapon for breast cancer treatment. ecancermedicalscience. 14. 1149–1149. 23 indexed citations
5.
Nardin, Simone, Francesca D’Avanzo, Valentina Rossi, et al.. (2020). Breast Cancer Survivorship, Quality of Life, and Late Toxicities. Frontiers in Oncology. 10. 864–864. 196 indexed citations
6.
Pinato, David J., Christopher C.T. Sng, Yien Ning Sophia Wong, et al.. (2020). 1679P Determinants of mortality from SARS-CoV-2 infection in European cancer patients. Annals of Oncology. 31. S995–S995.
7.
Gennari, Alessandra, Chiara Saggia, Valentina Rossi, Francesca D’Avanzo, & Paolo Bruzzi. (2018). Efficacy of CDK 4/6 inhibitors in ER positive metastatic breast cancer: Systematic review and meta-analysis of randomized clinical trials.. Journal of Clinical Oncology. 36(15_suppl). e13040–e13040. 1 indexed citations
8.
Mosca, Alessandra, Alessandro Volpe, Debora Beldì, et al.. (2016). Prostate cancer and androgen deprivation therapy: Metabolic, cardiovascular and psychological side effects. Acta Medica International. 3(2). 158–158. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026